Neurological Disorders: Page 2

Real-world study: Genetic testing appears underused in autism

By Emily Hayes

Neurological medicine researchers evaluated how frequently chromosomal microarray (CMA) and fragile X syndrome testing were conducted in people with autism spectrum disorder through the Rhode Island Consortium for Autism Research and Treatment (RI-CART). Results were reported by Dr. Eric Morrow, PhD, head of the Developmental Disorders Genetics Research Program at Brown University, and colleagues in a research letter.

May 13, 2020

Pathology study challenges conventional wisdom on brain injury

By Emily Hayes

The prospective Traumatic Head Injury Neuroimaging Classification (THINC) study was funded by the U.S. Department of Defense and the National Institute of Neurological Disorders and Stroke (NINDS).

October 14, 2019

FYR gets NIH small business grant for epilepsy diagnostics

By LabPulse.com staff writers

The grant was awarded by the NIH's National Institute of Neurological Disorders and Stroke, through the government's Small Business Innovation Research program. In the first phase of the funding, FYR Diagnostics will develop biomarkers for use in diagnostic kits.

October 9, 2019

Invitae offers 4 more no-charge genetic tests

By LabPulse.com staff writers

These four conditions were chosen because testing is underutilized, so there is room to improve diagnosis and treatment, the company explained in a statement. Patients who meet eligibility criteria can access Invitae's company- and organization-sponsored testing programs by enrolling through their doctors. The sponsors get deidentified information and contact information from participating clinicians.

July 23, 2019

Intensive blood sugar control has low value in acute stroke

By LabPulse.com staff writers

The trial -- dubbed the Stroke Hyperglycemia Insulin Network Effort (SHINE) -- compared intensive and standard blood glucose control using insulin in 1,151 acute stroke patients and showed good outcomes for 20% in both cohorts, Dr. Karen Johnston, chair of neurology at the University of Virginia, and colleagues reported (JAMA, July 23/30, 2019, Vol. 322:4, pp. 326-335).

July 23, 2019

Cerebrospinal fluid test helps pinpoint dementia disorders

By Emily Hayes

The meta-analysis of studies involving about 10,000 people with neurological disorders showed that neurofilament light protein as measured with a commercially available immunoassay was elevated for people with neurological and psychiatric conditions. Results were broadly similar; however, frontotemporal dementia and HIV-related cognitive decline were differentiated from other dementias, and Parkinson's disease was differentiated from atypical parkinsonian conditions.

June 17, 2019